SONOMA PHARMACEUTICALS, INC. (SNOA) Operating income 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) annual operating income history from SEC filings — each fiscal year as reported.
-$2.5MFY2026 · since FY2017: -$13.0M → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$2.5M | +33.7% |
| FY2025 | -$3.7M | +21.1% |
| FY2024 | -$4.7M | -2.9% |
| FY2023 | -$4.6M | +22.4% |
| FY2022 | -$5.9M | -70.7% |
| FY2021 | -$3.4M | +53.3% |
| FY2020 | -$7.4M | +34.4% |
| FY2019 | -$11.3M | +20.7% |
| FY2018 | -$14.2M | -9.4% |
| FY2017 | -$13.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice